• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

Voyager Ventures: Investment Portfolio & Startup News

Voyager Ventures

To add a bio or update investment portfolio click update information.

Investment Portfolio

    NewOrbit raises £14m in a Series A led by Voyager Ventures to build the first commercial satellites for very low Earth orbitNewOrbit raises £14m in a Series A led by Voyager Ventures to build the first commercial satellites for very low Earth orbit
    NewOrbit
    9 Jun 2026

    NewOrbit raises £14m in a Series A led by Voyager Ventures to build the first commercial satellites for very low Earth orbit

    NewOrbit builds satellites designed to operate in very low Earth orbit (VLEO), a band of near-Earth space at 200–300km altitude that has historically been inaccessible for commercial missions. Its satellites are engineered to withstand the aerodynamic drag, atomic oxygen corrosion, and destabilising torques that have made this orbit commercially unviable, enabling customers to access higher-resolution imagery and faster data connectivity at lower cost.

    Tem lands £55m Series B led by Lightspeed Venture Partners to fix the energy market with transaction infrastructureTem lands £55m Series B led by Lightspeed Venture Partners to fix the energy market with transaction infrastructure
    Tem
    10 Feb 2026

    Tem lands £55m Series B led by Lightspeed Venture Partners to fix the energy market with transaction infrastructure

    tem develops transaction infrastructure for energy markets. Its platform enables businesses and brokers to contract, buy and manage energy through a unified digital system.

Voyager Ventures
    • Deep Tech
    • Energy
  • 2(12 months)
  • voyagervc.com

More venture news

  • Zya lands a £12m Series A round led by Astanor to turn sugar in food into prebiotic fibre
    Zya
    16 Nov 2026

    Zya lands a £12m Series A round led by Astanor to turn sugar in food into prebiotic fibre

    Series AHealth
  • Oyster Therapeutics secures a £45m Series A round from CE-Ventures to develop an oral drug for neurodegenerative diseases
    Oyster Therapeutics
    13 Nov 2026

    Oyster Therapeutics secures a £45m Series A round from CE-Ventures to develop an oral drug for neurodegenerative diseases

    Series ALife Sciences
  • UFORCE secures a £530m Series A round led by Valor Equity Partners and UK National Wealth Fund to build uncrewed defence platforms
    UFORCE
    12 Nov 2026

    UFORCE secures a £530m Series A round led by Valor Equity Partners and UK National Wealth Fund to build uncrewed defence platforms

    Series ADefence

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn